The concept of “diabesity” stresses that diabetes and obesity must be managed as interconnected conditions. With several antidiabetic medications promoting weight gain, therapy choices should prioritise metabolic balance. 1 Effective management of diabesity emphasizes the use of antidiabetic agents that support weight loss alongside glycaemic control. Semaglutide has shown meaningful reductions in body weight, HbA1c, and insulin requirements, with a favorable safety profile.
2 Join us for an impactful clinical webinar on 11th January 2026 at 7:00 PM IST, where leading experts will address the rising burden of diabesity in everyday practice. The sessions will explore evolving real-world strategies for comprehensive metabolic management, including why semaglutide 1.0 mg is increasingly being adopted as a first-line option in eligible patients. ##References## Rehman Tet al. Indian Journal…
